HUT43575A - Process for producing amorphous benzimidazol derivatives and pharmaceutical compositions containing them - Google Patents
Process for producing amorphous benzimidazol derivatives and pharmaceutical compositions containing themInfo
- Publication number
- HUT43575A HUT43575A HU864893A HU489386A HUT43575A HU T43575 A HUT43575 A HU T43575A HU 864893 A HU864893 A HU 864893A HU 489386 A HU489386 A HU 489386A HU T43575 A HUT43575 A HU T43575A
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- producing amorphous
- benzimidazol derivatives
- benzimidazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80279885A | 1985-11-27 | 1985-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUT43575A true HUT43575A (en) | 1987-11-30 |
Family
ID=25184726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU864893A HUT43575A (en) | 1985-11-27 | 1986-11-26 | Process for producing amorphous benzimidazol derivatives and pharmaceutical compositions containing them |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0224249A1 (hu) |
| JP (1) | JPS62155263A (hu) |
| KR (1) | KR870004967A (hu) |
| AU (1) | AU6569886A (hu) |
| DK (1) | DK569786A (hu) |
| FI (1) | FI864812A (hu) |
| HU (1) | HUT43575A (hu) |
| IL (1) | IL80767A0 (hu) |
| NO (1) | NO864741D0 (hu) |
| PT (1) | PT83812B (hu) |
| ZA (1) | ZA868963B (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5419897A (en) * | 1993-04-09 | 1995-05-30 | Buckman Laboratories International, Inc. | Ionene polymers as anthelmintics in animals |
| US5861142A (en) * | 1996-03-25 | 1999-01-19 | Schick; Mary Pichler | Method for promoting hair, nail, and skin keratinization |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| AR035550A1 (es) * | 1999-06-04 | 2004-06-16 | Nufarm Ltd | Composiciones estables biocidas |
| US8697094B2 (en) * | 2002-10-16 | 2014-04-15 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
| US7622592B2 (en) | 2002-11-01 | 2009-11-24 | Merck & Co., Inc. | Carbonylamino-benzimidazole derivatives as androgen receptor modulators |
| AR087277A1 (es) | 2011-07-21 | 2014-03-12 | Bristol Myers Squibb Co | Composiciones biodisponibles de compuestos amorfos de piperidinilo, composicion farmaceutica, metodos |
| BR112021020257A2 (pt) | 2019-04-11 | 2021-12-07 | Bristol Myers Squibb Co | Desempenho intensificado de sólido amorfo e formulações solubilizadas para realizar concentrações de plasma terapêutico |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS601101A (ja) * | 1983-06-15 | 1985-01-07 | Yuukou Yakuhin Kogyo Kk | 水性懸濁農薬製剤 |
| DE3347579A1 (de) * | 1983-12-30 | 1985-07-11 | Hoechst Ag, 6230 Frankfurt | Zubereitungen schwer wasserloeslicher anthelminthika und verfahren zu ihrer herstellung |
-
1986
- 1986-11-26 EP EP86116396A patent/EP0224249A1/en not_active Withdrawn
- 1986-11-26 DK DK569786A patent/DK569786A/da not_active Application Discontinuation
- 1986-11-26 HU HU864893A patent/HUT43575A/hu unknown
- 1986-11-26 IL IL80767A patent/IL80767A0/xx unknown
- 1986-11-26 ZA ZA868963A patent/ZA868963B/xx unknown
- 1986-11-26 JP JP61283014A patent/JPS62155263A/ja active Pending
- 1986-11-26 PT PT83812A patent/PT83812B/pt unknown
- 1986-11-26 FI FI864812A patent/FI864812A/fi not_active IP Right Cessation
- 1986-11-26 AU AU65698/86A patent/AU6569886A/en not_active Abandoned
- 1986-11-26 NO NO864741A patent/NO864741D0/no unknown
- 1986-11-26 KR KR860009984A patent/KR870004967A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO864741D0 (no) | 1986-11-26 |
| EP0224249A1 (en) | 1987-06-03 |
| PT83812B (en) | 1988-03-15 |
| AU6569886A (en) | 1987-06-04 |
| KR870004967A (ko) | 1987-06-02 |
| IL80767A0 (en) | 1987-02-27 |
| DK569786A (da) | 1987-05-28 |
| FI864812A (fi) | 1987-05-28 |
| PT83812A (en) | 1986-12-01 |
| ZA868963B (en) | 1988-07-27 |
| FI864812A0 (fi) | 1986-11-26 |
| JPS62155263A (ja) | 1987-07-10 |
| DK569786D0 (da) | 1986-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT41790A (en) | Process for producing beta-amino-purine derivatives and pharmaceutical compositions containing them | |
| HUT48267A (en) | Process for producing fluoro-citidin derivatives and pharmaceutical compositions containing them | |
| HUT49316A (en) | Process for producing didehydro-d3-vitamine derivatives and pharmaceutical compositions containing them | |
| HUT40453A (en) | Process for producing 11-beta-phenyl-gonanes and pharmaceutical compositions containing them | |
| HUT51272A (en) | Process for producing thiadiazin derivatives and pharmaceutical composirions containing them | |
| HUT41772A (en) | Process for producing /4-substituted-piperazinyl- and -homopiperazinyl/-pyridazines and pharmaceutical compositions containing them | |
| HUT43825A (en) | Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| HUT44512A (en) | Process for producing bensyl derivatives and pharmaceutical compositions containing them | |
| HUT48887A (en) | Process for producing cyclopentenyl-purin derivatives and pharmaceutical compositions containing them | |
| HUT52061A (en) | Process for producing isoquinoline derivatives and pharmaceutical compositions containing them | |
| HUT56098A (en) | Process for producing azanaphtalenesultame derivatives and pharmaceutical compositions containing them | |
| HUT51277A (en) | Process for producing anellated tetrahydropyridin-acetic acid derivatives and pharmaceutical compositions containing them | |
| HUT42478A (en) | Process for producing gamma-carboline derivatives and pharmaceutical compositions containing them | |
| HUT59908A (en) | Process for producing benzazepine- and benzo-thiazepine derivatives and pharmaceutical compositions containing them | |
| HUT49317A (en) | Process for producing 16-dehydro-d3-vitamine derivatives and pharmaceutical compositions containing them | |
| GR860849B (en) | 4-demethyl -4- epipodophyllotoxin derivatives process for their preparation and their use as medicaments | |
| HUT47079A (en) | Process for producing n-amino-butyl-n-phenyl-aryl-amide derivatives and pharmaceutical compositions containing them | |
| HUT41035A (en) | Process for producing cepheme derivatives and pharmaceutical compositions containing them | |
| HUT48870A (en) | Process for producing aminoalkoxyphenyl derivatives and pharmaceutical compositions comprising same | |
| HUT41392A (en) | Process for producing new imidazolyl-alkyl-guanidine derivatives and pharmaceutical compositions containing them | |
| HUT43820A (en) | Process for producing n-(-2-((-2-hydroxy-phenyl-)(-phenyl-)-methylene-aminosquare )-ethyl-)-acetamide derivatives and pharmaceutical compositions containing them | |
| HUT39746A (en) | Process for producing cephalosporin derivatives and pharmaceutical compositions containing them | |
| HUT48244A (en) | Process for producing isoxazol-3-carbolin derivatives and pharmaceutical compositions containing them | |
| HUT58739A (en) | Process for producing 3-oxo-3-/benzopyrano- or -thiopyrano-pyrazol-3-yl/-propionitril derivatives and pharmaceutical compositions containing them | |
| HUT48270A (en) | Process for producing new purine derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |